Last reviewed · How we verify
NCT05710523: I-ACE
Integration Between Learning, Body and Emotions (I-ACE)
NA trial testing I-ACE training in Burnout, Professional in 270 participants. Status unknown.
30 August 2024
Quick facts
| Lead sponsor | Associazione Ginco Ticino |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 270 |
| Start date | 8 February 2021 |
| Primary completion | 30 August 2024 |
| Estimated completion | 28 February 2025 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- I-ACE training
- Standard non-pharmacological therapies (NPT) training
Conditions studied
- Burnout, Professional — all drugs for Burnout, Professional →
- Dementia — all drugs for Dementia →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Associazione Ginco Ticino
Who can join
Eligibility, any sex, with Burnout, Professional or Dementia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the effectiveness of training on non-pharmacological therapies (NPT) for people with dementia (PWD) on professional caregivers burnout and well-being in the relationship between caregivers and people with dementia (PWD) living in nursing home. The main questions it aims to answer are: * Does I-ACE training, that includes a training in the emotional-behavioral reading of body language and the recognition of one's own emotions and those of others, reduces professional caregiver burnout? * Does I-ACE training improves the ability to understand and respond to the emotions of the other starting from the signals expressed by the eyes, the activation of the predisposition to the relationship in terms of increase of salivary oxytocin, the sense of competence of the carers, the ethical climate at the workplace and the quality of life of the resident perceived by the team? Participants will attend twenty-two sessions: two theoretical meetings on dementia and NPT; ten supervision meetings on the methodology for implementing non-pharmacological therapies based on discussions of cases; ten meetings on the exploration of the bodily aspects involved in the relationship through theatrical exercises. The same cases will be re-discussed in the light of the body-emotional approach. Researchers will compare the I-ACE group with an active control group and an usual care control group to see if there are improvements in term of professional caregivers burnout, their ability to understand and respond to the emotions of PWD, increase of their levels of salivary oxytocin, sense of competence of the carers, the ethical climate at the workplace and the quality of life of the resident perceived by the team.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05710523
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burnout, Professional
Currently open trials in the same condition.
- NCT07221422 — The PREGNANT (Pregnant Resident Empowerment, GuidaNce, and Advocacy iN Training) Coaching Project · NA · recruiting
- NCT07423468 — Developing Competency Awareness and Clinical Coordination in a Neonatal Unit · NA · active not recruiting
- NCT07262372 — Supervision in Substance Use Disorder Treatment Programs · NA · recruiting
- NCT07089160 — Decision Fatigue and Emotional Exhaustion Among Anesthesiologists · recruiting
- NCT05942469 — Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) · NA · recruiting
Other Associazione Ginco Ticino trials
Trials by the same sponsor.
- NCT05814276 — San Rocco Study: Implementation of the Non-pharmacological Therapies for People With Dementia Living in Nursing Home · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05710523 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Associazione Ginco Ticino
- Last refreshed: 2 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05710523.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing